Clinical trial
Impact of Dexmedetomidine Supplemented Intravenous Analgesia on Postoperative Delirium and Long-term Outcomes in Elderly After Orthopedic Surgery: A Multicenter, Double-blinded, Randomized Controlled Trial
NCT03629262 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Dexmedetomidine Supplemented Intravenous Analgesia on Postoperative Delirium and Long-term Outcomes in Elderly After Orthopedic Surgery: A Multicenter, Double-blinded, Randomized Controlled Trial
- Lead sponsor
- Peking University First Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 28, 2018
- Completion date
- December 6, 2022
- Enrollment
- 712 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
analgesia, dexmedetomidine, elderly, long-term outcome, orthopedic surgery, postoperative delirium